Upgrades: ArcelorMittal ($MT) upgraded to Overweight from Neutral at JPMorgan Array Technologies ($ARRY) upgraded to Outperform from Neutral at Mizuho, Target: $5 Bank of America ($BAC) upgraded to Outperform from Neutral at Baird, Target: $62 BorgWarner ($BWA) upgraded to Buy from Neutral at BofA, Target: $85 Brighthouse Financial ($BHF) upgraded to Neutral from Underweight at …
Read in context ›Eloxx Pharmaceuticals Stock (ELOX)
Track Eloxx Pharmaceuticals stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
ELOX
Eloxx Pharmaceuticals
healthcare
$12.00
â–² +1.65 (+15.63%) past year
Market Cap
$56.07M
P/E Ratio
—
1Y Return
+15.63%
EPS (TTM)
—
Read the latest TheStreet Pro articles mentioning Eloxx Pharmaceuticals, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning ELOX yet.
Daily Diary Mentions
1 mentionUpgrades, Downgrades and New Research Coverage